|Bid||2.4000 x 2900|
|Ask||2.4800 x 1800|
|Day's Range||2.3400 - 2.5900|
|52 Week Range||1.9200 - 14.1800|
|Beta (5Y Monthly)||3.38|
|PE Ratio (TTM)||N/A|
|Earnings Date||May 12, 2021 - May 17, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||6.00|
ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, today reported financial and operating results for the year ended December 31, 2020 and provided a corporate strategic update.
NEW YORK, NY / ACCESSWIRE / March 17, 2021 / ThermoGenesis Holdings, Inc. (NASDAQ:THMO) will be discussing their earnings results in their 2020 Fourth Quarter Earnings call to be held on March 17, 2021 at 4:30 PM Eastern Time.
ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, today announced that the Company will release its financial results for the fourth quarter ended December 31, 2020 and provide a corporate strategic update on Wednesday, March 17, 2021, after the close of trading. A conference call and webcast will follow at 1:30 p.m. PT/ 4:30 p.m. ET.